Wei Quan Lu

US Patent:

20110190217, Aug 4, 2011

Filed:

Mar 28, 2011

Appl. No.:

13/073275

Inventors:

Bo Wang - Fort Lee NJ, US
Rui Rong Yuan - Fort Lee NJ, US
Wei Lu - Harrison NJ, US
Peter C. Dowling - Fort Lee NJ, US

International Classification:

A61K 38/12
A61P 29/00
A61P 25/00
A61P 25/28
A61P 25/16
A61P 27/02
A61P 27/00
A61P 27/16

US Classification:

514 178, 514 177, 514 179

Abstract:

The described invention provides methods for treating an inflammatory brain disease, disorder or condition and for treating a traumatic brain injury having an inflammatory component in a subject in need thereof using isolated erythropoietin (EPO)-derived oligopeptides.

US Patent:

20200376079, Dec 3, 2020

Filed:

Jun 5, 2020

Appl. No.:

16/894265

Inventors:

- Washington DC, US
Bo Wang - Fort Lee NJ, US
Rui Rong Yuan - Fort Lee NJ, US
Wei Lu - Harrison NJ, US

International Classification:

A61K 38/18
A61K 38/12

Abstract:

The described invention provides methods for treating an inflammatory brain disease, disorder or condition and for treating a traumatic brain injury having an inflammatory component in a subject in need thereof using isolated erythropoietin (EPO)-derived oligopeptides.

US Patent:

20180303903, Oct 25, 2018

Filed:

Jul 2, 2018

Appl. No.:

16/025827

Inventors:

Peter C. Dowling - Fort Lee NJ, US
Bo Wang - Fort Lee NJ, US
Rui Rong Yuan - Fort Lee NJ, US
Wei Lu - Harrison NJ, US

International Classification:

A61K 38/18
A61K 38/12
C07K 14/505

Abstract:

The described invention provides methods for treating an inflammatory brain disease, disorder or condition and for treating a traumatic brain injury having an inflammatory component in a subject in need thereof using isolated erythropoietin (EPO)-derived oligopeptides.

US Patent:

20170137483, May 18, 2017

Filed:

Jan 23, 2017

Appl. No.:

15/413398

Inventors:

Peter C. Dowling - Fort Lee NJ, US
Rui Rong Yuan - Fort Lee NJ, US
Wei Lu - Harrison NJ, US

International Classification:

C07K 14/505

Abstract:

The described invention provides compositions having EPO-derived peptides, and methods and kits for administering the EPO-derived peptide to a subject suffering from a neurodegenerative disease or an inflammatory disease of the brain or spinal cord. The EPO-derived peptide delays the onset and/or progression of a neurodegenerative disease, limits cognitive impairment in, and prolongs the survival of, subjects suffering from a neurodegenerative disease or an inflammatory disease of the brain or spinal cord.

US Patent:

20160303195, Oct 20, 2016

Filed:

Apr 22, 2016

Appl. No.:

15/136160

Inventors:

Bo Wang - Fort Lee NJ, US
Rui R. Yuan - Fort Lee NJ, US
Wei Lu - Harrison NJ, US
Peter Dowling - Fort Lee NJ, US

International Classification:

A61K 38/18

Abstract:

The described invention provides methods for treating an inflammatory brain disease, disorder or condition and for treating a traumatic brain injury having an inflammatory component in a subject in need thereof using isolated erythropoietin (EPO)-derived oligopeptides.

US Patent:

20160271206, Sep 22, 2016

Filed:

Mar 11, 2013

Appl. No.:

13/792336

Inventors:

Wei Lu - Sea Girt NJ, US
Peter C. Dowling - Ft. Lee NJ, US
Rong Yuan - Ft. Lee NJ, US

International Classification:

A61K 38/10

Abstract:

The described invention provides methods and kits for administering an EPO-derived peptide to a subject suffering from a neurodegenerative disease. The EPO-derived peptide delays the onset and/or progression of a neurodegenerative disease, limits cognitive impairment in, and prolongs the survival of, subjects suffering from a neurodegenerative disease.